Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126646571 | 12664657 | 1 | I | 201607 | 20160816 | 20160818 | 20160818 | EXP | PHEH2016US020743 | NOVARTIS | 81.74 | YR | Y | 0.00000 | 20160818 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126646571 | 12664657 | 1 | PS | PROMACTA | ELTROMBOPAG OLAMINE | 1 | Oral | 75 MG, QD | 22291 | 75 | MG | TABLET | QD | ||||||
| 126646571 | 12664657 | 2 | SS | PROMACTA | ELTROMBOPAG OLAMINE | 1 | 22291 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126646571 | 12664657 | 1 | Myelodysplastic syndrome |
| 126646571 | 12664657 | 2 | Bone marrow failure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126646571 | 12664657 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126646571 | 12664657 | Cardiac failure | |
| 126646571 | 12664657 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126646571 | 12664657 | 1 | 201607 | 0 |